Early prenatal biochemical screening, present state, current problems and options

Tat'yana Konstantinovna Kascheeva , Yukiya Anatolevna Nikolaeva , Vladislav Sergeevich Baranov , Konstantin Romanovich Karpov , Nataliya Vasilevna Vokhmyanina , Olga Panteleymonovna Romanenko

Journal of obstetrics and women's diseases ›› 2012, Vol. 61 ›› Issue (3) : 69 -74.

PDF
Journal of obstetrics and women's diseases ›› 2012, Vol. 61 ›› Issue (3) : 69 -74. DOI: 10.17816/JOWD61369-74
Articles
research-article

Early prenatal biochemical screening, present state, current problems and options

Author information +
History +
PDF

Abstract

In Saint-Petersburg total biochemical screening for Down’s syndrome in 2-d trimester have been established since 1997. Also all pregnant women underwent ultrasound examinations for screening for chromosomal abnormalities. Results of introduction of 1-st trimester combined screening since 2006, its influence for detection rate, achievements and problems were discussed in our paper

Keywords

Down’s syndrome / prenatal diagnosis / chromosome abnormalities

Cite this article

Download citation ▾
Tat'yana Konstantinovna Kascheeva, Yukiya Anatolevna Nikolaeva, Vladislav Sergeevich Baranov, Konstantin Romanovich Karpov, Nataliya Vasilevna Vokhmyanina, Olga Panteleymonovna Romanenko. Early prenatal biochemical screening, present state, current problems and options. Journal of obstetrics and women's diseases, 2012, 61(3): 69-74 DOI:10.17816/JOWD61369-74

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

1. Внедрение алгоритма комбинированного скрининга хромосомной патологии плода в 1 триместре беременности. Опыт работы за 4 года / Некрасова Е. С. [и др.] // Журнал акушерства женских болезней. — 2007. — № 1. — С. 28–34.

[2]

2. Итоги массового биохимического скрининга беременных в Санкт-Петербурге (2008–2009) / Кащеева Т. К. [и др.] // Молекулярно-биологические технологии в медицинской практике. Вып. 14 / ред. А. Б. Масленников. — Новосибирск, 2010. — С. 160–165.

[3]

3. Николаидес К. Ультразвуковое исследование в 11–13 недель беременности. — СПб.: Петрополис, 2007. — 144 с.

[4]

4. Cовременные алгоритмы пренатальной диагностики наследственных болезней: метод. пособие / Баранов В. С. [и др.]. — СПб.: Изд-во Н-Л, 2009. — 130 с.

[5]

5. Cuckle H. S. Monitoring quality control of nuchal translucency // Clin. Lab. Med. — 2010. — Vol. 30. — P. 593–604.

[6]

6. Danish Fetal Medicine Reseach Group. Impact of new national screening policy for Down’s screening in Denmark: population based cohort study / Ekelund C. K. [et al.] // Br. Med. J. — 2008. — Vol.337. — a2547.

[7]

7. Evans M. I., Van Decruyes H., Nikolaides K. H. Nuchal translucency measurements for first trimester screening: the “price” of inaccuracy // Fetal Diag. Ther. — 2007. — Vol. 22. — P. 401–404.

[8]

8. First trimester combined screening for trisomy 21 at 8–13 weeks / Wright D. [et al.] // Ultrasound Obstet. Gynecol. — 2010. — Vol. 36. — P. 404–411.

[9]

9. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A / Kagan K. O. [et al.] // Ultrasound Obstet. Gynecol. — 2008. — Vol. 31. — P. 619–624

RIGHTS & PERMISSIONS

Kascheeva T.K., Nikolaeva Y.A., Baranov V.S., Karpov K.R., Vokhmyanina N.V., Romanenko O.P.

AI Summary AI Mindmap
PDF

53

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/